389 related articles for article (PubMed ID: 21372253)
41. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
[TBL] [Abstract][Full Text] [Related]
42. Role of renal function and cardiac biomarkers (NT-proBNP and Troponin) in determining mortality and cardiac outcome in atheromatous renovascular disease.
Chrysochou C; Manzoor S; Wright J; Roberts SA; Wood G; McDowell G; Kalra PA
Kidney Blood Press Res; 2009; 32(5):373-9. PubMed ID: 19887825
[TBL] [Abstract][Full Text] [Related]
43. Prognostic value of coronary artery calcium screening in subjects with and without diabetes.
Raggi P; Shaw LJ; Berman DS; Callister TQ
J Am Coll Cardiol; 2004 May; 43(9):1663-9. PubMed ID: 15120828
[TBL] [Abstract][Full Text] [Related]
44. Abnormal indices of autonomic function are no longer predictors of poor outcome in diabetic patients without neuropathy but with coexisting coronary artery disease who receive optimal pharmacological therapy.
Ponikowska B; Jankowska EA; Reczuch K; Wegrzynowska-Teodorczyk K; Witkowski T; Rydlewska A; Borodulin-Nadzieja L; Banasiak W; Francis D; Ponikowski P
Kardiol Pol; 2009 Dec; 67(12):1325-32. PubMed ID: 20054763
[TBL] [Abstract][Full Text] [Related]
45. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
J Hypertens; 2008 Jan; 26(1):26-34. PubMed ID: 18090537
[TBL] [Abstract][Full Text] [Related]
46. Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes.
Coppola G; Corrado E; Mulè MC; Augugliaro S; Cucchiara A; Novo G; Amoroso G; Assennato P; Hoffmann E; Vitale F; Novo S
Coron Artery Dis; 2009 May; 20(3):225-9. PubMed ID: 19387249
[TBL] [Abstract][Full Text] [Related]
47. Sensitive troponin and N-terminal probrain natriuretic peptide in stable angina.
Ndrepepa G; Braun S; Schulz S; Fusaro M; Keta D; Pache J; Seyfarth M; Mehilli J; Schömig A; Kastrati A
Eur J Clin Invest; 2011 Oct; 41(10):1054-62. PubMed ID: 21413976
[TBL] [Abstract][Full Text] [Related]
48. A cross sectional study comparing traditional risk factors with N-terminal pro-BNP in high risk groups for cardiovascular disease in Trinidad, West Indies.
Shivananda Nayak B; Teelucksingh S; Jagessar A; Maharaj S; Maharaj N
Diabetes Metab Syndr; 2013; 7(1):8-11. PubMed ID: 23517788
[TBL] [Abstract][Full Text] [Related]
49. Plasma N-terminal Pro-Brain Natriuretic Peptide (Nt-proBNP) level and prognosis after myocardial infarction in diabetes.
Vergès B; Zeller M; Beer JC; Cottin Y;
Diabetes Metab; 2008 Feb; 34 Suppl 1():S10-5. PubMed ID: 18358421
[TBL] [Abstract][Full Text] [Related]
50. Predictive value of NT-proBNP in vascular surgery patients with COPD and normal left ventricular systolic function.
van Gestel YR; Goei D; Hoeks SE; Sin DD; Flu WJ; Stam H; Mertens FW; Bax JJ; van Domburg RT; Poldermans D
COPD; 2010 Feb; 7(1):70-5. PubMed ID: 20214466
[TBL] [Abstract][Full Text] [Related]
51. Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide: a Clopidogrel for the Reduction of Events During Observation (CREDO) substudy.
Tang WH; Steinhubl SR; Van Lente F; Brennan D; McErlean E; Maroo A; Francis GS; Topol EJ
Am Heart J; 2007 Jan; 153(1):36-41. PubMed ID: 17174634
[TBL] [Abstract][Full Text] [Related]
52. Increased plasma concentrations of N-terminal pro-B-type natriuretic peptide in patients with mild primary hyperparathyroidism.
Almqvist EG; Becker C; Bondeson AG; Bondeson L; Svensson J; Svensson SE
Clin Endocrinol (Oxf); 2006 Dec; 65(6):760-6. PubMed ID: 17121527
[TBL] [Abstract][Full Text] [Related]
53. N-terminal pro-B-type natriuretic peptide in risk stratification after acute myocardial infarction in patients on long-term beta-adrenergic receptor blocker therapy.
Jonsson G; Abdelnoor M; Landaas S; Muller C; Kjeldsen SE; Os I; Westheim A
Cardiology; 2006; 106(2):102-8. PubMed ID: 16636540
[TBL] [Abstract][Full Text] [Related]
54. N-terminal pro-B-type natriuretic peptide: an independent marker for coronary artery disease in asymptomatic diabetic patients.
Cosson E; Nguyen MT; Pham I; Pontet M; Nitenberg A; Valensi P
Diabet Med; 2009 Sep; 26(9):872-9. PubMed ID: 19719707
[TBL] [Abstract][Full Text] [Related]
55. N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes.
Grauslund J; Nybo M; Green A; Sjølie AK
Scand J Clin Lab Invest; 2010 Oct; 70(6):392-8. PubMed ID: 20575653
[TBL] [Abstract][Full Text] [Related]
56. Predictive value of serum NT-proBNP levels in type 2 diabetic people with diabetic nephropathy.
Danis R; Ozmen S; Arikan S; Gokalp D; Alyan O
Diabetes Res Clin Pract; 2012 Mar; 95(3):312-6. PubMed ID: 22018780
[TBL] [Abstract][Full Text] [Related]
57. The severity of coronary artery disease and reversible ischemia revealed by N-terminal pro-brain natriuretic peptide in patients with unstable angina and preserved left ventricular function.
Xu L; Qian W; Li W; Liu J; He H; Li G; Cao Y; Yu Y
Peptides; 2014 Feb; 52():143-8. PubMed ID: 24412773
[TBL] [Abstract][Full Text] [Related]
58. Joint effects of N-terminal pro-B-type-natriuretic peptide and C-reactive protein vs angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable coronary artery disease.
Dai DF; Hwang JJ; Lin JL; Lin JW; Hsu CN; Lin CM; Chiang FT; Lai LP; Hsu KL; Tseng CD; Tseng YZ
Circ J; 2008 Aug; 72(8):1316-23. PubMed ID: 18654020
[TBL] [Abstract][Full Text] [Related]
59. NT-proBNP for prognostic and diagnostic evaluation in patients with acute coronary syndromes.
Zdravkovic V; Mladenovic V; Colic M; Bankovic D; Lazic Z; Petrovic M; Simic I; Knezevic S; Pantovic S; Djukic A; Zdravkovic N
Kardiol Pol; 2013; 71(5):472-9. PubMed ID: 23788087
[TBL] [Abstract][Full Text] [Related]
60. NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis.
Reinhard H; Wiinberg N; Hansen PR; Kjær A; Petersen CL; Winther K; Parving HH; Rossing P; Jacobsen PK
Cardiovasc Diabetol; 2011 Aug; 10():71. PubMed ID: 21812947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
